Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.54 |
| ▸ | DPP4 | P27487 | 5/20 | 0.47 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7414769 | 0.94 | HDAC1 (0.46) | HDAC1HDAC6DPP4FABP4MEN1 | |
| SCHEMBL7422336 | 0.91 | FABP4 (0.57) | HDAC1HDAC6DPP4FABP4MEN1 | |
| SCHEMBL7474547 | 0.87 | HDAC1 (0.52) | HDAC1HDAC6DPP4FABP4ALDH1A1 | |
| SCHEMBL7423051 | 0.86 | DPP4 (0.45) | HDAC1HDAC6DPP4FABP4MEN1 | |
| SCHEMBL7418839 | 0.84 | FABP4 (0.54) | HDAC1HDAC6DPP4FABP4MEN1 | |
| SCHEMBL7467571 | 0.81 | DPP4 (0.44) | DPP4FABP4MEN1ALDH1A1KMT2A | |
| SCHEMBL7473427 | 0.81 | DPP4 (0.46) | HDAC1HDAC6DPP4FABP4MEN1 | |
| SCHEMBL7416251 | 0.76 | ALDH1A1 (0.54) | DPP4FABP4MEN1ALDH1A1KMT2A | |
| SCHEMBL5147078 | 0.75 | HDAC1 (0.48) | HDAC1HDAC6MEN1KMT2APTGS1 | |
| SCHEMBL7422984 | 0.73 | DPP4 (0.47) | DPP4FABP4MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0820441-B1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-06-26 | — | — | EP | disclosed |
| US-6358992-B1 | Method of inhibiting neoplastic cells with indole derivatives | CELL PATHWAYS, INC. | 2002-03-19 | — | — | US | disclosed |
| US-6069156-A | Indole derivatives as cGMP-PDE inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-30 | — | — | US | disclosed |
| EP-0820441-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996032379-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-17 | — | — | WO | disclosed |